News

10.03.20 Medannex announces new immunomodulatory approach to cancer treatment at Nature conference
16.02.20 Medannex shortlisted in two categories at Scotland’s Life Sciences Awards
02.11.19 Dr Stefan Symeonides to guide Medannex’s Phase I trial preparation
02.10.19 Medannex begins cell line development at FUJIFILM Diosynth
14.08.19 Ian Abercrombie joins Medannex as Chief Executive Officer
18.07.19 Medannex announces £11 million Series B investment
  1. 1
  2. 2